← Browse by Condition
Medical Condition

deep vein thrombosis

Total Trials
4
Recruiting Now
4
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for deep vein thrombosis sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — deep vein thrombosis Clinical Trials

How many clinical trials are currently recruiting for deep vein thrombosis?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for deep vein thrombosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for deep vein thrombosis?
deep vein thrombosis research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a deep vein thrombosis clinical trial?
Eligibility criteria for deep vein thrombosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
First Affiliated Hospital of Zhejiang University 1 trial
ThrombUS+ 1 trial
Medical University of South Carolina 1 trial
Medalp Private Surgery Clinic 1 trial

Recruiting Clinical Trials

NCT04694248
Recruiting

Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting

Enrollment
172 pts
Location
China
Sponsor
First Affiliated Hospital of Z...
View Trial →
NCT06989255
Recruiting

A Multi-center Cohort Study for Conventional Ultrasound Image Set Collection to Create a Data Set for Research Purposes.

Enrollment
3,000 pts
Location
France, Greece, Ital...
Sponsor
ThrombUS+
View Trial →
NCT06451003
Recruiting

Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery

Enrollment
30 pts
Location
United States
Sponsor
Medical University of South Ca...
View Trial →
NCT03881345
Recruiting

Ongoing Registry of Treatment of Venous Thromboembolism

Enrollment
5,000 pts
Location
Russia
Sponsor
Medalp Private Surgery Clinic
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology